Computer Aided Detection Market Growth and Regional Forecast Upto 2024
The global computer aided detection (CAD) market is in its early stages of growth and is increasingly reliant on the market dynamics of corresponding imaging modalities for market penetration. The growing usage of CAD software solutions for a number of diagnostic applications such as cardiovascular, oncology, musculoskeletal, and neurological has made the market highly specific, dynamic, and competitive with significant growth potential. The revenue generated by the global CAD market was pegged at US$437 mn in 2015 and is anticipated to cross US$1 bn by 2024. The market is expected to expand at a strong CAGR of 9.8% from 2016 to 2024.
Read a Comprehensive Overview of Computer Aided Detection Market: http://www.transparencymarketresearch.com/computer-aided-detection.html
Computer Aided Detection Most Widely Used in Breast Cancer Screening
Computer aided detection technology finds application mainly in oncology and cardiovascular and neurological indications. Breast cancer was the leading application segment of the market in 2015 and is projected to sustain its position during the forecast period. Its dominance can be attributed to the increasing number of breast cancer detection applications and a lower risk of observational errors by using CAD solutions in combination with mammography. Favorable reimbursement scenario for breast cancer CAD solutions in developed nations and its well-established identity as a supplement tool in the diagnosis of breast cancer also contribute to the growth of the segment. The prostate cancer application segment is projected to expand at the fastest growth rate from 2016 to 2024. This can be attributed to the increasing number of regulatory approvals for various prostate cancer detection CAD solutions and the rising incidence of the disease.
Growing Incidence and Prevalence of Breast Cancer in U.S. Driving North America Market
Geographically, the computer aided detection market has been segmented into five major regions: North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America held the leading share in the global computer aided detection market in terms of revenue in 2015, followed by Europe. The dominance of these two regions is owing to the rising incidence and prevalence of breast cancer, the growing awareness level about early screening of breast cancer, an increase in the geriatric population, and rapid advancement in various healthcare technologies. The U.S. forms the most significant market for computer aided detection in North America as well as globally as it is an important innovation hub and leading companies in the segment have been conducting thorough research and development. Moreover, the World Cancer Research Fund (WCRF) statistics show that North America reported the highest number of new breast cancer cases in 2012, with around 226,125 in the U.S. alone. This also acts as a growth driver for the computer aided detection market in the region.
Asia Pacific is also a prominent market for computer aided detection. The region accounts for over 60% of the world’s population, which translates to a significant patient pool and large number of imaging procedures. According to the Asian Pacific Journal of Cancer Prevention (2010), there were over 3 million new cancer cases and over 2 million cancer deaths in Asia. Projections suggest the number of new cancer cases in Asia will increase to 7.1 million by 2020 if existing prevention and management strategies remain unchanged. However, most of the countries in the region are positioning themselves as medical tourism destinations for developed nations. This will encourage healthcare providers to adopt advanced computer aided detection in imaging technologies.
Request a sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1442
Key players in the computer aided detection market include Agfa-Gevaert N.V., Fujifilm Medical Systems USA, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Samsung Medison Co. Ltd, and Philips Healthcare.
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Computer Aided Detection Market Growth and Regional Forecast Upto 2024 here
News-ID: 587854 • Views: 245
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
More Releases for Aided
Computer Aided Detection (CAD) Market Size, Share | Industry Report 2026
The global Computer Aided Detection Market was valued at $5018.3million in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $million. Computer Aided Detection is a aims to mark regions of interest on a digitized mammogram image to prevent overlooking by the human reader to applies a pattern recognition algorithm and claimed not to be a diagnostic tool.
Computer Aided Engineering (CAE) Market - Current Outlook by 2025
Global Computer Aided Engineering (CAE) Market: Overview Computer-aided engineering (CAE) is a term used by the electronic design automation (EDA) industry. The term is assigned to computer software leveraged to design, examine, and produce products and processes. CAE includes computer-aided design (CAD) which entails the use of a computer for creating designs and computer-aided manufacturing (CAM) which involves use of computers for carrying out manufacturing. Computer-aided engineering (CAE) works by
Computer-Aided Diagnosis Benefitting Medical Image Analysis Software
There is the strong and growing need in the biology research community for accurate, automated image analysis and CellProfiler 2.0 has been engineered to meet the needs of its growing user base with more robustness and user friendly features along with new algorithms and features to facilitate high-throughput work. In addition, Amide's a Medical Image Data Examiner (AMIDE) and Halo Image Analysis Platform by Indica Labs are user friendly, software
Computer Aided Detection Market Estimated to Cross (Revenues) by 2024
Incidences of various types of cancers such as lung, prostate, breast and colorectal cancer is gradually increasing. For instance, the American Cancer Society estimated that more than one Mn people in U.S. are diagnosed with cancer every year and in 2012, 14.1 Mn new cases of cancer were reported. It has also been reported that in the same year, 8.2 Mn people died of cancer, which accounted for 14% of
Sri Lanka cement demand expansion aided by infrastructure investments
Greenwich (CT), USA, May 29, 2017 – According to CW Research’s “2017 Sri Lanka Cement Market Report”, the country’s cement demand rose 13 percent per annum on average from 2010 to 2016. In the next five years, demand is expected to continue growing, albeit at a more moderate pace as public works and infrastructure investments slow. Between 2010 and 2016, the country’s cement demand was driven by investment in infrastructure
Computer Aided Detection Market Analysis – 2024
The global computer aided detection market is extremely consolidated, with the top five players – namely Hologic, Inc., GE Healthcare, Invivo Corporation, Siemens Healthcare, and Agfa-Gevaert N.V. – accounting for nearly three quarters of the market in 2014. Transparency Market Research finds that among these, Hologic alone held a share of 35% that year, emerging as the clear leader. “A diversified product portfolio, well-timed acquisition strategies, and extensive geographical presence